Detalles de la búsqueda
1.
TRPV4: Molecular Conductor of a Diverse Orchestra.
Physiol Rev
; 96(3): 911-73, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27252279
2.
HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
Eur Radiol
; 2023 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921926
3.
REPLY TO THORNELOE ET AL.
Physiol Rev
; 97(4): 1233-1234, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794167
4.
Large-scale prediction and testing of drug activity on side-effect targets.
Nature
; 486(7403): 361-7, 2012 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722194
5.
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Support Care Cancer
; 25(1): 85-92, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557833
6.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 16(9): 1071-1078, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272768
7.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Lancet Oncol
; 16(9): 1079-1089, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272769
8.
A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.
Nat Commun
; 14(1): 4323, 2023 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468498
9.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36223558
10.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725084
11.
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial.
J Thorac Oncol
; 17(2): 289-308, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648948
12.
The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors.
Bioorg Med Chem Lett
; 21(16): 4909-12, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21742496
13.
Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes.
Toxicol Sci
; 180(2): 356-368, 2021 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33483756
14.
Acute cell stress screen with supervised machine learning predicts cytotoxicity of excipients.
J Pharmacol Toxicol Methods
; 111: 107088, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34144174
15.
Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016.
Pathol Oncol Res
; 27: 598862, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34257553
16.
Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011-2016.
Pathol Oncol Res
; 27: 603937, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34257563
17.
Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
Pathol Oncol Res
; 27: 1610041, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35002544
18.
Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.
bioRxiv
; 2021 Mar 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33791693
19.
Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016.
Pathol Oncol Res
; 27: 1609916, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34594159
20.
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2.
Science
; 373(6554): 541-547, 2021 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326236